Zhang Xile,Yang Ruijie,Li Jun,et al.Analysis of dosimetric verification results of stereotactic body radiotherapy[J].Chinese Journal of Radiological Medicine and Protection,2019,39(9):680-685
Analysis of dosimetric verification results of stereotactic body radiotherapy
Received:January 10, 2019  
DOI:10.3760/cma.j.issn.0254-5098.2019.09.008
KeyWords:Stereotactic body radiotherapy  Dosimetric verification  Interpolation  Dose calculation grid size  Dose assessment threshold
FundProject:国家自然科学基金(81071237,81372420)
Author NameAffiliationE-mail
Zhang Xile Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China  
Yang Ruijie Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China ruijyang@yahoo.com 
Li Jun Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China  
An Daojian Department of Radiation Oncology, Chenyang People's Hospital, Qingdao 266109, China  
Li Jiaqi Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China  
Wang Junjie Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China  
Hits: 4231
Download times: 1777
Abstract::
      Objective To analyze the patient-specific dosimetric verification result of stereotactic body radiotherapy (SBRT) plans, and to investigate the sensitivity of the result to three factors:interpolation of measured data, size of dose calculation grid and assessment threshold. Methods The dosimetric verification results of SBRT plans of 50 patients were retrospectively analyzed to evaluate the impact of the following factors. The linear interpolation (1.00 mm) and non-interpolation (7.62 mm) were applied to measured data respectively. Three dose calculation grid sizes of Eclipse planning system, i.e., 1.0 mm, 2.5 mm and 4.0 mm were compared respectively. The threshold of dose assessment was selected as 10%, 20% and 30%, respectively. Three criteria of γ analysis were selected:2%/2 mm, 3%/2 mm and 3%/3 mm. Results Under criteria of 2%/2 mm, 3%/2 mm and 3%/3 mm, the average γ passing rates were (86.3±7.3)% and (93.7±5.6)%, (94.1±4.4)% and(97.7±3.9)%, (97.7 ±2.2)% and (99.1±1.7)%, respectively, with and without linear interpolation. Relative to the 1.0 mm reference grid, the grids of 2.5 mm and 4.0 mm significantly decreased γ passing rates by 3.8%, 1.9%, 0.8% (t=8.41, 9.06, 5.30, P<0.05) and by 6.5%, 6.0%, 3.5% (t=-13.76, -13.15, -9.80, P<0.05) under criteria of 2%/2 mm, 3%/2 mm and 3%/3 mm, respectively. Relative to the 10% reference threshold, the shresholds of 20% and 30% significantly decreased γ passing rates by 2.4%, 1.0%, 0.6%(t=-8.60, -5.86, -4.68, P<0.05) and by 4.0%, 1.7%, 0.9% (t=-9.45, -6.66, -5.06, P<0.05) under criteria of 2%/2 mm, 3%/2 mm and 3%/3 mm, respectively. Conclusions Interpolation, dose calculation grid size and dose assessment threshold are influential factors of dose verification result, and need to be considered during dosimetric verification of stereotactic radiotherapy patients.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12030284  On-line:0

v
Scan QR Code
&et=6FD48CA0A0DD4759943105C4B28DC0342A4683D086EA832CDC7FE7C8BA79B47C0FD73FA86185579DC0E8962B8F424D9713B464AFD2522A32C50F870D24E46D064CDD2DECBD3E415B5657029EF700B4E9&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B6351343F4791CA3&aid=7BA62EAAEF4CF3CAC68256AB9928569F&vid=&iid=9CF7A0430CBB2DFD&sid=34D13857B558254E&eid=AF14A8B15FB15A64&fileno=20190908&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B6351343F4791CA3"; var my_aid="7BA62EAAEF4CF3CAC68256AB9928569F";